"Porter Regional Hospital is owned in part by physicians."

During the past decade, Porter Memorial Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 4 clinical trials were completed, i.e. on average, 400% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Porter Memorial Hospital" #1 sponsor was "SWOG Cancer Research Network" with 4 trials, followed by "National Cancer Institute (NCI)" with 2 trials sponsored, "ConvaTec Inc." with 1 trials sponsored, "Inotek Pharmaceuticals Corporation" with 1 trials sponsored and "Radiation Therapy Oncology Group" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Porter Memorial Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator, "Millennium Pharmaceuticals, Inc." with 1 trials as a collaborator and "Roche-Genentech" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Porter Memorial Hospital" are "Acute Myocardial Infarction" (1 trials), "Breast Cancer" (1 trials), "Breast Ductal Carcinoma In Situ" (1 trials), "Colorectal Cancer" (1 trials) and "Colorectal Neoplasms" (1 trials). Many other conditions were trialed in "Porter Memorial Hospital" in a lesser frequency.

Most popular intervention types in "Porter Memorial Hospital" are "Drug" (8 trials), "Other" (3 trials), "Biological" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole" (1 trials), "Bicalutamide" (1 trials), "Clinical Observation" (1 trials), "Eflornithine placebo & sulindac" (1 trials) and "Eflornithine placebo & sulindac placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Porter Memorial Hospital" are 6 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Porter Memorial Hospital". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Porter Memorial Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Porter Memorial Hospital, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".